Tender detail
Open-house rebate agreements for medicines containing brivaracetam
Summary
The procurement concerns non-exclusive rebate agreements for medicines containing the active ingredient brivaracetam (ATC N03AX23), under an open-house model. Agreements may be concluded at any time for the period from 1 January 2027 to 31 December 2028. Medicines listed as paediatric medicines by the BfArM under Section 35(5a) SGB V are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.